$NTRB

NutriBand Inc.

CIK:0001676047|SEC Filings

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2026	Jul. 31, 2025	Jul. 31, 2026	Jul. 31, 2025
Income Statement [Abstract]
Revenue	$ 437,514	$ 622,452	$ 870,913	$ 1,289,884
Costs and expenses:
Cost of revenues	255,640	465,571	492,238	881,022
Research and development	322,194	562,554	569,455	1,245,980
Selling, general and administrative	750,317	1,597,540	1,954,208	2,579,592
Total Costs and Expenses	1,328,151	2,625,665	3,015,901	4,706,594
Loss from operations	(890,637)	(2,003,213)	(2,144,988)	(3,416,710)
Other income (expense):
Interest income	14,950	8,649	32,353	39,157
Interest expense	(4,874)	(5,773)	(9,882)	(11,653)
Total other income (expense)	10,076	2,876	22,471	27,504
Loss before provision for income taxes	(880,561)	(2,000,337)	(2,122,517)	(3,389,206)
Provision for income taxes
Net loss	(880,561)	(2,000,337)	(2,122,517)	(3,389,206)
Preferred shares dividend		(21,814,166)		(21,814,166)
Net loss available to common stockholders - basic	(880,561)	(23,814,503)	(2,122,517)	(25,203,372)
Net loss available to common stockholders - diluted	$ (880,561)	$ (23,814,503)	$ (2,122,517)	$ (25,203,372)
Net loss per share attributable to common stockholders - basic	$ (0.07)	$ (2.12)	$ (0.17)	$ (2.26)
Net loss per share attributable to common stockholders - diluted	$ (0.07)	$ (2.12)	$ (0.17)	$ (2.26)
Weighted average common shares outstanding - basic	12,155,983	11,218,581	12,155,983	11,172,543
Weighted average common shares outstanding - diluted	12,155,983	11,218,581	12,155,983	11,172,543

Unaudited Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jul. 31, 2026	Jul. 31, 2025
Cash flows from operating activities:
Net loss	$ (2,122,517)	$ (3,389,206)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	67,503	114,862
Operating lease expense	18,000	18,000
Loss on extinguishment of debt
Stock-based compensation-shares, options and warrants issued for services	772,828	104,400
Changes in operating assets and liabilities:
Accounts receivable	94,812	(86,957)
Prepaid expenses	(25,972)	(29,842)
Inventories	(52,746)	74,010
Deferred revenue	(20,182)	(136,461)
Operating lease liability	(21,692)	(13,158)
Accounts payable and accrued expenses	141,863	694,039
Net Cash Used In Operating Activities	(1,148,103)	(2,650,313)
Cash flows from investing activities:
Purchase of equipment		(5,324)
Net Cash Used in Investing Activities		(5,324)
Cash flows from financing activities:
Purchase of treasury stock	(1,060)
Proceeds from the exercise of employee stock options		44,206
Proceeds from sale of common stock and exercise of warrants		5,305,503
Payment on note payable	(4,079)	(10,690)
Net Cash Provided by Financing Activities	(5,139)	5,339,019
Net change in cash	(1,153,242)	2,683,382
Cash and cash equivalents - Beginning of period	4,574,857	4,311,719
Cash and cash equivalents - End of period	3,421,615	6,995,101
Cash paid for:
Interest	1,250	1,250
Income taxes
Supplemental disclosure of non-cash investing and financing activities:
Cashless conversion of warrants		82
Measurement of operating lease right-of-use assets and liabilities		108,000
Debt settlement issued by the issuance of common stock and warrants
Preferred Shares issued as Common stock dividend		$ 21,814,166

Consolidated Balance Sheets (Unaudited) - USD ($)	Jul. 31, 2026	Jan. 31, 2026
CURRENT ASSETS:
Cash and cash equivalents	$ 3,421,615	$ 4,574,857
Accounts receivable-net	23,592	118,404
Inventory-net	170,733	117,987
Prepaid expenses	203,443	177,470
Total Current Assets	3,819,383	4,988,718
PROPERTY & EQUIPMENT-net	530,085	567,255
OTHER ASSETS:
Goodwill	1,719,535	1,719,535
Operating lease right of use asset	54,000	72,000
Intangible assets-net	170,094	200,427
TOTAL ASSETS	6,293,097	7,547,935
CURRENT LIABILITIES:
Accounts payable and accrued expenses	644,518	502,654
Deferred revenue	100,121	120,303
Operating lease liability-current portion	33,967	32,453
Notes payable-current portion	128,442	128,871
Total Current Liabilities	907,048	784,281
LONG-TERM LIABILITIES:
Note payable-net of current portion	25,099	35,861
Operating lease liability-net of current portion	32,211	48,305
Total Liabilities	964,358	868,447
Commitments and Contingencies
STOCKHOLDERS’ EQUITY:
Preferred stock, $.001 par value, 10,000,000 shares authorized, -3,008,643 and -3,008,643 - issued and outstanding as of July 31, 2026 and January 31, 2026, respectively	3,009	3,009
Common stock, $.001 par value, 291,666,666 shares authorized, 12,174,883 and 12,174,883 shares issued at July 31, 2026 and January 31, 2026, respectively, 12,155,683 and 12,155,883 shares outstanding as of July 31, 2026 and January 31, 2026, respectively	12,156	12,156
Additional paid-in-capital	54,216,575	53,443,747
Accumulated other comprehensive loss	(304)	(304)
Treasury stock, 18,900 and 18,900 shares at cost, as of April 30, 2026 and January 31, 2026, respectively	(87,912)	(86,852)
Accumulated deficit	(48,814,785)	(46,692,268)
Total Stockholders’ Equity	5,328,739	6,679,488
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 6,293,097	$ 7,547,935